We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Key TxCell Patent to be Granted in the US for its Lead Product Ovasave®

News   Mar 19, 2015

 
Key TxCell Patent to be Granted in the US for its Lead Product Ovasave®
 
 
 

RELATED ARTICLES

Why Some Sufferers of Chronic Infections Wither Away

News

Researchers showed that some chronic viral infection led to a severe reorganization of the architecture of the fat tissue and cachexiain triggered by CD8+ T cells.

READ MORE

Inhaled Steroids No Better Than Placebo for Many Asthma Sufferers

News

A study of nearly 300 patients with mild persistent asthma found that inhaled steroids—long considered the gold standard for asthma treatment—were no more effective than placebo in nearly 75 % of the study patients.

READ MORE

First Ever Video of T Cell "Safety Training"

News

Immunologists have captured on video what happens when T-cells – the contract killers of the immune system – undergo a type of assassin-training program before they get unleashed in the body.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE